On December 14, 2023, Hasten Biopharmaceutical Co., Ltd. announced that it will enter into a strategic business partnership with Apeloa Pharmaceutical Co., Ltd.

Summer XIA Shaofei, CEO of Hasten, said, “We are very pleased to form a strategic business partnership with Apeloa. Apeloa has outstanding pharmaceutical manufacture facilities, R&D capabilities, and quality control systems, which provide a good collaboration platform for the development of global innovative pharmaceutical companies. This cooperation will better help Hasten realize its corporate mission of 'providing high-quality medicines and solutions that improve lives of people and create social value’."